newsfilter
← Latest News
PR Newswire·

Elevation Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Business Achievements

Partner CSPC Pharmaceutical Group Limited's ongoing Phase 1 SYSA1801 (EO-3021) clinical trial data selected for poster presentation and poster discussion at ASCO 2023Presented EO-3021 preclinical proof-of-concept